Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H de Mulder

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNUJ H Schornagel, J Verweij, P H de Mulder, et al.
Clinical Immunology and Immunopathology|March 1, 1983
Increased antibody-dependent cytotoxicity mediated by purified monocytes in Hodgkin's diseaseP H de Mulder, B E de Pauw, A Pennings, et al.
International Journal of Cancer|December 22, 1999
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEPR de Wit, M Louwerens, P H de Mulder, et al.
The Clinical Journal of Pain|September 1, 1989
Epidural administration of morphine for control of cancer pain: long-term efficacy and complicationsJ J Driessen, P H de Mulder, J J Claessen, et al.
Seminars in Surgical Oncology|January 1, 1988
Alpha and gamma interferon in the treatment of advanced renal cell carcinomaA D Geboers, P H de Mulder, F M Debruyne, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
The 5-HT3 receptor antagonist ondansetron re-establishes control in refractory emesis induced by non-cisplatin chemotherapyC Seynaeve, P H de Mulder, E Lane-Allman, et al.
Cancer|April 1, 1995
Metastatic breast cancer presenting as fever, rash, and arthritisJ P Drenth, E H de Kleijn, P H de Mulder, et al.
Scandinavian Journal of Haematology|July 1, 1980
Spontaneous transformation of low density lymphocytes as parameter of activity in Hodgkin's diseaseB E de Pauw, P H de Mulder, J B Smeulders, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Coincidence of seminoma and sarcoidosis: a myth or fact?V C Tjan-Heijnen, L T Vlasveld, F P Pernet, et al.
British Journal of Cancer|February 1, 1995
EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary GroupP H De Mulder, G Oosterhof, C Bouffioux, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNUJ H Schornagel, J Verweij, P H de Mulder, et al.
Clinical Immunology and Immunopathology|March 1, 1983
Increased antibody-dependent cytotoxicity mediated by purified monocytes in Hodgkin's diseaseP H de Mulder, B E de Pauw, A Pennings, et al.
International Journal of Cancer|December 22, 1999
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEPR de Wit, M Louwerens, P H de Mulder, et al.
The Clinical Journal of Pain|September 1, 1989
Epidural administration of morphine for control of cancer pain: long-term efficacy and complicationsJ J Driessen, P H de Mulder, J J Claessen, et al.
Seminars in Surgical Oncology|January 1, 1988
Alpha and gamma interferon in the treatment of advanced renal cell carcinomaA D Geboers, P H de Mulder, F M Debruyne, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 1, 1991
The 5-HT3 receptor antagonist ondansetron re-establishes control in refractory emesis induced by non-cisplatin chemotherapyC Seynaeve, P H de Mulder, E Lane-Allman, et al.
Cancer|April 1, 1995
Metastatic breast cancer presenting as fever, rash, and arthritisJ P Drenth, E H de Kleijn, P H de Mulder, et al.
Scandinavian Journal of Haematology|July 1, 1980
Spontaneous transformation of low density lymphocytes as parameter of activity in Hodgkin's diseaseB E de Pauw, P H de Mulder, J B Smeulders, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Coincidence of seminoma and sarcoidosis: a myth or fact?V C Tjan-Heijnen, L T Vlasveld, F P Pernet, et al.
British Journal of Cancer|February 1, 1995
EORTC (30885) randomised phase III study with recombinant interferon alpha and recombinant interferon alpha and gamma in patients with advanced renal cell carcinoma. The EORTC Genitourinary GroupP H De Mulder, G Oosterhof, C Bouffioux, et al.
Pageof 14